Introduction
Background
Thyroiditis refers to inflammation of the thyroid gland. Subacute thyroiditis (SAT) is a self-limited condition characterized by a triphasic course of hyperthyroidism followed by hypothyroidism and ending with euthyroidism. Subacute thyroiditis may account for 15-20% of thyrotoxicosis presentations and 10% of hypothyroidism presentations. The thyrotoxicosis results from release of preformed thyroid hormone. This phase lasts 4-10 weeks. The disease undergoes remission in 2-4 months. At this time, the thyroid is depleted of colloid and is now incapable of producing thyroid hormone, resulting in hypothyroidism. The hypothyroidism may be mild and not requiring any therapy. As the follicles regenerate, the euthyroid state is restored. Up to 95% of patients return to this normal thyroid state.
The term subacute thyroiditis (SAT) conventionally has been used interchangeably with subacute granulomatous (de Quervain) thyroiditis, which was the first syndrome described as causing inflammation and release of preformed hormone from the gland.
Pathophysiology
Subacute thyroiditis has been thought to have viral origins. Most patients have a history of an upper respiratory infection 2-8 weeks prior to the onset of thyroiditis. Therefore, more cases occur in the summer. The search for a viral cause is often unrewarding. A few cases appear to be associated with the mumps virus. High titers of mumps antibodies have been found in some patients with subacute thyroiditis, and, occasionally, parotitis or orchitis is associated with thyroiditis. The mumps virus has been cultured directly from thyroid tissue involved with subacute thyroiditis. The disease has also been reported in association with other viral conditions, including measles, influenza, adenovirus, infectious mononucleosis, myocarditis, cat scratch fever, and coxsackievirus.
Numerous attempts to culture viruses from cases not associated with mumps have failed. However, viral antibody titers to common respiratory tract pathogens often are elevated in these patients. Because the titers fall promptly and multiple viral antibodies may appear in the same patient, the elevation probably is an anamnestic response to the inflammatory condition.
An autoimmune reaction is unlikely. During the illness, the development of cell-mediated immunity against various thyroid cell particulate fractions or crude antigens appears to be related to the release of these materials during tissue destruction. Data on the mechanism of inflammation and the pathogenesis of subacute thyroiditis at the cellular level are sparse.
The role of growth factors has received some attention. In the granulomatous stage of subacute thyroiditis, growth factor–rich monocytes and/or macrophages infiltrating into follicle lumina are thought to trigger the granulomatous reaction, and vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), and transforming growth factor beta 1 (TGF-β1) produced by the stromal cells probably mediate the reaction. In the regenerative phase, endothelial growth factor (EGF) mediates follicle regeneration through its mitogenic effect on thyrocytes, along with cofactors. In addition, the decreased expression of TGF-β1, a fibrogenic factor, contributes to thyroid tissue repair. VEGF and bFGF may be responsible for angiogenesis in both stages.
A genetic predisposition has been linked to subacute thyroiditis. Patients with the human leukocyte antigen (HLA)-Bw35 haplotype seem to have a higher predilection for SAT.1 In one study, as many as 72% of patients with SAT manifested HLA-Bw35. In the presence of this haplotype, the virus probably acquires the ability to trigger a cytotoxic T-cell response against the thyroid. In Japanese patients, an association with HLA-B67 seems to exist. In this population, 87% of patients with subacute thyroiditis had either HLA-B35 or HLA-B67. HLA-B67 was associated with a greater risk of developing a hypothyroid phase when compared to patients with HLA-Bw35.Frequency
United States
Subacute thyroiditis is uncommon. The reported incidence is 1 case in 10,000. The presence of the HLA-Bw35 haplotype confers a greater predilection for subacute thyroiditis by 6-fold, when compared to the general population.
Sex
A female preponderance exists, with a female-to-male ratio of 3-5:1.
Age
The disease has been reported in persons of all ages. Subacute thyroiditis is more common between the third and fifth decades of life. It is uncommon in childhood.
Clinical
History
- Pain is the predominant symptom. While the pain may be limited to the region of the thyroid, it may also involve the upper neck, throat, jaw or ears. Some patients may first consult an otolaryngologist. The pain may be so severe that the patient cannot tolerate palpation of the neck. The pain is most commonly bilateral. Occasionally, the pain may be unilateral, beginning in one lobe and spreading to the opposite side (creeping thyroiditis). Coughing, swallowing, or even tightening a necktie aggravates pain.
- Systemic symptoms, including fatigue, malaise, and myalgia, are common. Fever (up to 104ºF) may also be present.
- Thyrotoxic symptoms may be absent, mild, or moderate but rarely are severe. Up to 50% of the patients present with hyperthyroidism. Patients may complain of nervousness, heat intolerance, palpitations, tremulousness, and increased sweating.
Physical
- The thyroid is mildly to moderately enlarged, usually 2-3 times its normal size. It is exquisitely tender to palpation.
- Rarely, the patient may present with a solitary nodule and tenderness.
- The gland is firm to hard in consistency. The swelling is diffuse and involves the entire gland but may involve one lobe.
- The presentation of hyperthyroidism may manifest with fever, tachycardia, and hyperreflexia.
- Orbitopathy and dermopathy, which are characteristic of Graves disease, are absent.
Causes
While most cases of subacute thyroiditis are secondary to a viral illness, other causes of subacute thyroiditis (SAT) exist and include the following:
- Subacute thyroiditis has been described in patients receiving interferon-alpha for chronic hepatitis.
- Radioiodine therapy for Graves disease can result in transient thyroidal inflammation, causing thyroiditis.
- Subacute thyroiditis also has been described following external radiation to the neck.
- Subacute thyroiditis has presented as a paraneoplastic manifestation of renal cell carcinoma.
- An association between subacute thyroiditis and febrile neutrophilic dermatoses (Sweet syndrome) has been reported.
- Concurrence of giant cell arteritis has been reported in patients with classic de Quervain thyroiditis.
- Subacute thyroiditis has been described after bone marrow transplantation for chronic granulocytic leukemia.
- Amiodarone may produce a painful thyroiditis with thyrotoxicosis.2 While the major cause of amiodarone-induced thyrotoxicosis is iodine overload in a gland with underlying abnormalities, a direct toxic effect is observed in some patients.
More on Thyroiditis, Subacute |
Overview: Thyroiditis, Subacute |
| Differential Diagnoses & Workup: Thyroiditis, Subacute |
| Treatment & Medication: Thyroiditis, Subacute |
| Follow-up: Thyroiditis, Subacute |
| References |
| Next Page » |
References
Ohsako N, Tamai H, Sudo T. Clinical characteristics of subacute thyroiditis classified according to human leukocyte antigen typing. J Clin Endocrinol Metab. Dec 1995;80(12):3653-6. [Medline].
Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med. Jul 2005;118(7):706-14.
Salvi A, Spandrio S, Tosoni M. Liver enzyme abnormalities in subacute thyroiditis. Recenti Prog Med. Nov 1990;81(11):686-8. [Medline].
Bianda T, Schmid C. De Quervain's subacute thyroiditis presenting as a painless solitary thyroid nodule. Postgrad Med J. Oct 1998;74(876):602-3. [Medline].
Bindra A, Braunstein GD. Thyroiditis. Am Fam Physician. May 15 2006;73(10):1769-76.
Chopra IJ, van Herle AJ, Korenman SG. Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis. J Clin Endocrinol Metab. Jul 1995;80(7):2178-80. [Medline].
Garcia Solano J, Gimenez Bascunana A, Sola Perez J. Fine-needle aspiration of subacute granulomatous thyroiditis (De Quervain's thyroiditis): a clinico-cytologic review of 36 cases. Diagn Cytopathol. Mar 1997;16(3):214-20. [Medline].
Hamburger JI. The various presentations of thyroiditis. Diagnostic considerations. Ann Intern Med. Feb 1986;104(2):219-24. [Medline].
Hay ID. Thyroiditis: a clinical update. Mayo Clin Proc. Dec 1985;60(12):836-43. [Medline].
Hiromatsu Y, Ishibashi M, Miyake I. Color Doppler ultrasonography in patients with subacute thyroiditis. Thyroid. Dec 1999;9(12):1189-93. [Medline].
Hiromatsu Y, Ishibashi M, Miyake I. Technetium-99m tetrofosmin imaging in patients with subacute thyroiditis. Eur J Nucl Med. Oct 1998;25(10):1448-52. [Medline].
Houghton DJ, Gray HW, MacKenzie K. The tender neck: thyroiditis or thyroid abscess?. Clin Endocrinol (Oxf). Apr 1998;48(4):521-4. [Medline].
Iitaka M, Momotani N, Ishii J. Incidence of subacute thyroiditis recurrences after a prolonged latency: 24-year survey. J Clin Endocrinol Metab. Feb 1996;81(2):466-9. [Medline].
Kannan CR, Seshadri KG. Thyrotoxicosis. Dis Mon. Sep 1997;43(9):601-77. [Medline].
Koga M, Hiromatsu Y, Jimi A. Immunohistochemical analysis of Bcl-2, Bax, and Bak expression in thyroid glands from patients with subacute thyroiditis. J Clin Endocrinol Metab. Jun 1999;84(6):2221-5. [Medline].
Lazarus JH. Silent thyroiditis and subacute thyroiditis. In: Braverman LE, Utiger RD, eds. The Thyroid: A fundamental and Clinical Text. Philadelphia, Pa:. JB Lippincott;1996:577.
Lio S, Pontecorvi A, Caruso M. Transitory subclinical and permanent hypothyroidism in the course of subacute thyroiditis (de Quervain). Acta Endocrinol (Copenh). May 1984;106(1):67-70. [Medline].
Mizukami Y, Michigishi T, Kawato M. Immunohistochemical and ultrastructural study of subacute thyroiditis, with special reference to multinucleated giant cells. Hum Pathol. Sep 1987;18(9):929-35. [Medline].
Ross DS. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinol Metab Clin North Am. Mar 1998;27(1):169-85. [Medline].
Sakata S, Nagai K, Maekawa H. Serum ferritin concentration in subacute thyroiditis. Metabolism. Jul 1991;40(7):683-8. [Medline].
Shabb NS, Tawil A, Gergeos F. Multinucleated giant cells in fine-needle aspiration of thyroid nodules: their diagnostic significance. Diagn Cytopathol. Nov 1999;21(5):307-12. [Medline].
Watts NB, Sewell CW. Carcinomatous involvement of the thyroid presenting as subacute thyroiditis. Am J Med Sci. Aug 1988;296(2):126-8. [Medline].
Further Reading
Keywords
subacute thyroiditis, SAT, subacute granulomatous thyroiditis, de Quervain thyroiditis, de Quervain's thyroiditis, giant cell thyroiditis, pseudogranulomatous thyroiditis, pseudo-granulomatous thyroiditis, painless thyroiditis, lymphocytic thyroiditis, inflamed thyroid, inflammation of the thyroid gland, hyperthyroidism, hypothyroidism, euthyroidism, thyrotoxicosis, thyroid disease
Overview: Thyroiditis, Subacute